Table 3.
Fibroblast growth factor-23 | P-value | ||
---|---|---|---|
Below the median | Above the median | ||
LVEF (%) | 63 ± 8 | 63 ± 7 | 0.92 |
EDV (ml) | 153 ± 35 | 154 ± 37 | 0.91 |
EDV index (ml/m2) | 72 ± 13 | 70 ± 15 | 0.29 |
ESV (ml) | 58 ± 22 | 59 ± 24 | 0.75 |
ESV index (ml/m2) | 27 ± 9 | 27 ± 10 | 0.78 |
SV (ml) | 95 ± 21 | 95 ± 20 | 0.89 |
LV mass (g) | 138 ± 36 | 143 ± 40 | 0.04 |
LV mass index (g/m2) | 62 ± 13 | 66 ± 16 | 0.03 |
LA volume (ml) | 91 ± 25 | 97 ± 27 | 0.07 |
LA volume index (ml/m2) | 41 ± 11 | 44 ± 11 | 0.10 |
Rest MBF (ml/min/g) | 0.81 ± 0.19 | 0.83 ± 0.18 | 0.69 |
Stress MBF (ml/min/g) | 2.7 ± 0.9 | 2.3 ± 0.9 | 0.001 |
MPR | 3.3 ± 1.1 | 2.7 ± 0.8 | < 0.001 |
Average E/e* | 7.6 ± 2.7 | 8.5 ± 3.2 | 0.04 |
Extracellular volume (%) | 27.8 ± 3.5 | 28.6 ± 3.2 | 0.51 |
Data presented as mean ± SD. LVEF left ventricular ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, LA left atrial, MBF myocardial blood flow, MPR myocardial perfusion reserve. Significant differences indicated in bold.